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Abstract 
The Collaboration 1n Ammal Health and Food Safety Epidemiology (CAHFSE), a USDA JOint 
program of ARS, APHIS, and FSIS was established to track food borne pathogens and monitor 
animal health issues. Fecal samples (n=9020) were collected and cultured for Salmonella from 
pens of p1gs near slaughter we1ght (generally~ 22 weeks old) from swine farms 1n five U.S. states. 
A prevalence of 8.0, 10.1, and 8.5% was observed 1n 2003, 2004, and 2005, respectively The top 
10 serotypes accounted for 94% of the total Salmonella isolates with S. Derby (45%), S. 
Typhimurium var. 5- (15%), and S Heidelberg (9%) comprising the top three serotypes each year. 
Salmonella G1ve was found in 8% of samples in 2003, 3% of samples m 2004, but was not found in 
the top 10% of ISolates m 2005. The percentage of Salmonella isolates that were susceptible to all 
of the 16 antimicrobials tested increased from 6% in 2003 to 15% in 2005. At the same time, the 
percentage of 1solates res1stant to 1 0 or more antim1crob1als increased from 1% to 15%. The 
mcrease 1n multiple drug res1stance was comc1dent with an mcrease 1n the percentage of S. Derby 
isolates. Overall, frequency of resistance to individual antimicrobials was relatively stable from 
2003 to 2005 and observed differences were related to changes in serotypes over time, which 
highlights the Importance of reporting res1stance data by mdiv1dual serotype. CAHFSE prov1des a 
mechanism to monitor changes 1n serotypes of Salmonella as well as antimicrobial resistance 
patterns over t1me 
Introduction 
Salmonella have been linked to food animal production and pork products are cons1dered to be 
potential sources of Salmonella (WJ'lite, et al. 2001 ). Nontypho1dal Salmonella spp. are estimated 
to account for 1 4 million cases of gastroenteritis in humans annually in the Un1ted States (Mead et 
al 1999) Most cases result 1n self-lim1t1ng diarrheal d1sease However, prolonged durat1on of 
1llness, sept1cemia or altered immune function 1n some Individuals may warrant use of antimicrobial 
therapy (Conte, 1995). Therefore , 1t IS Important to ma1ntam an effect1ve array of ant1m1crob1als for 
potential treatment of bacterial infections. 
The emergence of ant1m1crob1al res1stance 1n zoonot1c bactena assoc1ated w1th food produc1ng 
ammals, and evidence of human infections from an1mal sources (Fey, et al , 2000, Cohen and 
Tauxe, 1986) has spurred public health officials and sc1enllsts to reassess ant1m1crob1al use m food 
animal production (FDA, 1998, WHO, 1997) In food animal production, ant1m1crob1als are used 
both therapeutically and non-therapeutically It 1s believed that therapeutic treatment of mdividual 
animals plays a m1nor role 1n the development of resistance However, prolonged exposure of 
ammals to non-therapeutic levels of ant1m1crob1als for the prevention of disease and performance 
enhancement is believed to have the potential to mcrease antim1crob1al res1stance 
The results of the Nat1onal Animal Health Momtonng System's (NAHMS) Swme 2000 study 
1nd1cated ant1m1crobials were g1ven 1n feed to growerlfimsher pigs on 88.5% of the swine 
operations (APHIS, 2002) accounting for 95 9% of the growerlfin1sher p1gs m the Un1ted States 
Thus. antim1crob1al use and related 1ssues are a major concern to the pork mdustry The merit and 
consequences of both therapeutic and non-therapeutic use of ant1m1crobials 1s under 1ncreasmg 
scrut1ny but little information IS available comparing the effects of these usage levels on the 
development and pers1stence of antim1crob1al res1stance among food borne pathogenic bactena 
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Prev1ous monitoring programs have consisted of short-term studies of the presence of 
antimicrobial resistant populations, particularly in zoonotic pathogens associated with farm 
animals. To enhance and expand these initial monitoring efforts, a multi-agency "Public Health 
Action Plan to Combat Antimicrobial Resistance" was developed to address the potentially adverse 
effects of using antimicrobials in food animal produ'ction. The United States Department of 
Agnculture (USDA) responded by developmg the Collaboration on Animal Health and Food Safety 
Epidemiology (CAHFSE), a partnership among USDA agencies; Animal and Plant Health 
Inspection Service (APHIS), Agricultural Research Service (ARS) and Food Safety and Inspection 
Service (FSIS). The primary objectives of CAHFSE are: 1) to enhance the overall understanding 
of pathogens that pose a food-safety risk by tracking these pathogens from the farm to the plant 
and 2) to monitor critical diseases in food-animal production. These objectives and critical issues 
related to the relationship between antim1crob1al susceptibility and antimicrobial use will be 
addressed on a long term continuous basis under the CAHFSE program. Swine were the first 
commodity tested m the CAHFSE program. 
Materials and Methods 
On-Farm Sampling 
CAHFSE sampling began in July, 2003 and by December 31 , 2005, a total of 9020 fecal samples 
from 5 states (Iowa, Minnesota, Missouri, North Carolina and Texas) were tested for the presence 
of Salmonella. Selection criteria for soliciting farm part1cipat1on included production types (indoor 
farrow-to-finish. outdoor farrow-to-finish, indoor finish only, and outdoor finish only) and size 
(number of pigs marketed per year; small~ 2,000, medium > 2,000 and ~ 7,500, large > 7,500). 
Samples and data were collected quarterly. During each site visit, a questionnaire regarding clmmal 
mventory, animal health, management practices and ant1microb1al use was completed. 
Up to 40 pen noor fecal samples were collected from pigs at least 22 wks old for isolatron and 
subsequent charactenzation of Salmonella. At least 5 samples per pen (center and at each 
corner) were taken for each of 8 pens. When there were less than 8 pens. then two or more sets 
of samples were taken from the same pen. Approximately 25 gm fecal samples were collected 
with a clean tongue depressor and placed 1n Whirl Pack bags. Liquid diarrhea fecal samples were 
placed in 50 ml centrifuge tubes, the screw caps were tightly secured and also placed m Wh1rl 
Pack bags Samples were then shrpped overnight on frozen cold packs to the Richard B Russell 
Agriculture Research Center in Athens, Georgia. 
Salmonella 
Feces (1 g) was Incubated in 10 ml of GN HaJna (D1fco, Becton Dickenson, Sparks. MD) for 18-24 
h at 37° C, and Tetrathionate broth (D1fco) for 40-48 h at 37° C. After the mit1al ennchments, 
aliquots (100 ~I) were transferred to 10 ml of Rappaport-Vassiliadis R10 broth (Difco) which were 
mcubated for 18-24 hat 37° C. Ten microliter aliquols of Rappaport-Vassiliadis R10 broth were 
then streaked onto Xylose-Lysine-Tergitol-4 (Difco) and BG Sulfa (Difco) agar for isolation of 
Salmonella Plates were incubated for 18-24 h at 3JD C. Isolated colonies charactenst1c of 
Salmonella were inoculated into triple sugar iron and lysine iron agar slants for biochemical 
confirmation. Presumptive positive isolates were serogrouped using serogroup specific antisera 
(Difco) and were then sent to the National Veterinary Services Laboratory (Ames. lA) for 
serotyping. 
Antimicrobial Susceptibility Testing 
Salmonella, generic E. coli and Enterococcus antim1crob1al susceptibility testing were conducted 
using the SensititreTM System (Trek Diagnostics, Inc .. Westlake. Ohio) as per manufacturer's 
directions. Antimicrobials Included those used in both human and veterinary medicine and were 
configured in a 96 well custom made panel. National Committee for Clinical Standards (NCCLS) 
(renamed to Clime I and Laboratory Standards Institute's (CLSI)) gUidelines and resistance 
breakpoints were used throughout the testing procedure. 
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Results 
Salmonella were recovered from 8 0, 10 1, and 8.5% of tested U.S. pigs in 2003, 2004, and 2005, 
respectively (Table 1) 
Table 1 Salmonella prevalence 22 wk-old-p1gs from five U S. states 
2003 2004 2005 
Samples tested I 763 3.377 3.881 
tlumber of 143 338 330 
POSib~o?S 
Pr~ alen ~ 81% 100% 85% 
The top 10 serotypes accounted for 94% of the total Salmonella isolates with S Derby (45%), S 
Typh1munum var 5- (15%), and S Heidelberg (9%) compns1ng the top three serotypes each year 
Salmonella Give was found in 8% of samples in 2003, 3% of samples in 2004, but was not found 1n 
the top 10% of isolates in 2005 (Table 2). 
Table 2: Predominate serotypes of Salmonella from US pigs, 2003-2005 
Rank 2003 I 2004 2005 
n=146 n=356 n=346 
Serotype Percent Serotype Percent Serotype Percent 
---
-I- - - f- -
1 Darby 310% Derby 4521 ".4 Derby 43 93".4 
- -2 Typhvar 5- 276% Typh V1ll 5- 1396% He1deberg 11 85°.4 
3 Ha1daberg 997% He1deberg 7 92".4 Typh var 5- 1156% 
4 GIVe 759% Typhomunum 660% Typh1munum 751% 
5 Mbandaka 690% Untypeble 4 29".4 Mbandaka 665% 
-
--;- -I- - 1---
6 TyphlTTltlnum 483% G,.,. 396% A goo a 4 62% 
7 Untypabla 345% Mbandaka 330% Worthmgton 347".4 
-· 
~ 
9 lnfanbs 2 07"4 Anatum 330% Untypable 2 60".4 
9 Worthnglon 1 39"4 BOYIS- 264% 4.512J .• 2 02".4 
-
- ~ 
Morblflcans_J I Newport -10 80YIS· 1 38'% Wortlwlgton 231% 116".4 
Morbiflcans I 
The percentage of Salmonella isolates that were susceptible to all of the 16 antimicrobials tested 
mcreased from 6% m 2003 to 15°'o in 2005 At the same time the percentage of isolates res1stant 
to 10 or more antimicrobials increased from 1 °'o to 15% The mcrease m multiple drug res1stance 
was comc1dent w1th an mcrease m the percentage of S Derby isolates (Table 3) 
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Table 3: Multiple antimicrobial susceptibility of Salmonella from U.S. pigs, 2003-2005 
No. of ABX 2003 2004 2005 
n=146 n=356 n=346 
Pan- 5.5 5.3 15.0 
Susceptible 
1 29.7 33.3 10.7 
>2 64.8 61 .4 74.3 
>5 21.4 28.7 30.6 
>10 1.4 9.5 152 
Discussion 
Salmonella prevalence m swine fecal samples were similar to earlier reports (Bush et al., 1999). In 
addition Salmonella serotypes recovered m this study were typ1cal of those reported 1n U.S. swine 
product1on Resistance among Salmonella 1solates was observed most frequently among 
antimicrobial agents used extensively in the past (streptomycm, sulfonam1des, and tetracycline). 
Overall, frequency of res1stance to individual antim1crob1als was relatively stable from 2003 to 2005 
and observed differences were related to changes in serotypes over time, wh1ch highlights the 
importance of reporting resistance data by individual serotype. QUinolones are not approved for 
use in swine in the U S. and no isolates resistant to ciproOoxacin were observed Since any use of 
antim1crob1als can result in selection of resistant bacterial populations, antibiotics should only be 
used when warranted to treat disease or to enhance the healthy growth of animals 
CAHFSE provides a mechanism to monitor changes in serotypes of Salmonella as well as 
antimicrobial res1stance patterns over time. 
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